Ateb licenses Walgreens' entire portfolio of prescription alignment patents

Ateb on Thursday announced it has reached an agreement to license Walgreens' entire portfolio of prescription alignment patents in an effort to continue to improve overall health care, demonstrate the value of medication synchronization and increase patient adherence rates.

Want to Read More?

This content is available only to registered users. Log in to read the rest of this article or create a free account.

Login or Register to post a comment.